Mission Therapeutics' executive director, Dr Anker Lundemose. Mission Therapeutics of the UK has struck a deal to out-license a drug for acute kidney injury to Australia's Dimerix, allowing it to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results